The FDA issued EUA for first antigen test to help in rapid detection of virus that causes COVID-19 in patients
On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
On May 8, 2020, the U.S. Food and Drug Administration (FDA) issued the first emergency use authorization (EUA)…
On May 8, 2020, RedHill Biopharma announced the U.S. Food and Drug Administration (FDA) had approved its Investigational…
On May 8, 2020, Quidel announced it had received Emergency Use Authorization (EUA) from the FDA to market…
On May 7, 2020, Royal DSM announced it had started manufacturing nose swabs for the first time to…
On May 7, 2020, City of Hope announced that two existing drugs using advanced genomic technology, were being…
On May 7, 2020, Gilead announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted…
On May 7, 2020, OPTI Medical Systems, an IDEXX Laboratories subsidiary announced the U.S. Food and Drug Administration…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
On May 7, 2020, Washington University in St. Louis announced that people with COVID-19 who are seen by…
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On May 6, 2020, IGEA Pharma announced that an evaluation by the University of Miami Miller School of…
On May 6, 2020, bioMerieux announced performance validation and the launch of VIDAS anti-SARS-CoV-2 serology tests to detect…
On May 6, 2020, Laurent Pharmaceuticals announced that it has obtained the approval from Health Canada to initiate…
On May 6, 2020, the U.S. Food and Drug Administration (FDA) approved Tabrecta (capmatinib) for the treatment of…
On May 5, 2020, PerkinElmer announced the FDA provided Emergency Use Authorization (EUA) for EUROIMMUN’s (a PerkinElmer company)…
On May 5, 2020, Tyson Foods announced resumption of limited production at its Waterloo, Iowa facility May 7….
On May 5, 2020, a team of researchers at the McGovern Institute for Brain Research at MIT, the…
On May 5, 2020, LabCorp announced that its COVID-19 Immunoglobulin G (IgG) antibody test is now available for…
On May 4, 2020, Vir Biotech and Alnylam Pharma announced the selection of a development candidate for VIR-2703,…
On May 4, 2020, Anixa Biosciences and partner OntoChem, announced they had identified its first therapeutic candidate against…
On May 4, 2020, Mayo Clinic was awarded a $26 million contract from the Biomedical Advanced Research and…
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
On May 4, 2020, the U.S. Patent and Trademark Office (USPTO) unveiled a new web-based intellectual property marketplace…
On May 4, 2020, bioMerieux announced that BioFire Diagnostics, its subsidiary specialized in syndromic infectious disease testing, has…
On May 3, 2020, AbCellera announced it had received a commitment of up to $175.6 million in support…
On May 2, 2020, Roche announced that the FDA has issued an Emergency Use Authorization for its new…
On May 1, 2020, a University of Southern California (USC) study suggested that temporarily suppressing the body’s immune…
On May 1, 2020, the U.S. Dept. of Veterans Affairs (VA) announced participation in a series of clinical…